# Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma

> **NCT07136519** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Affiliated Hospital of Guangdong Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma (NPC)

## Interventions

- **DRUG:** Toripalimab
- **DIETARY_SUPPLEMENT:** Omega-3
- **RADIATION:** radiotherapy
- **DRUG:** Paclitaxel (albumin bound)
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT07136519
- **Lead sponsor:** Affiliated Hospital of Guangdong Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-22
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07136519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07136519, "Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07136519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*